Literature DB >> 32981596

Another Brick in the Wall: Sintilimab Plus Chemotherapy in Advanced Lung Cancer.

Vincent K Lam1, Patrick M Forde2.   

Abstract

Entities:  

Year:  2020        PMID： 32981596     DOI： 10.1016/j.jtho.2020.08.013

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN： 1556-0864            Impact factor:   15.609


× No keyword cloud information.
  5 in total

1.  Asynchrony of primary tumor and mediastinal lymph nodes response after neoadjuvant immunotherapy plus chemotherapy in a patient with stage IIIA non-small-cell lung cancer: a case report.

Authors:  Yunpeng Liu; Zhiru Gao; Chengbin Zhang; Xing Liu; Zihao Liu; Xingyu Lin; Benxin Qian; Fukang Jin; Guoguang Shao; Zhiguang Yang
Journal:  Anticancer Drugs       Date:  2022-01-01       Impact factor: 2.248

2.  Safety and efficacy of sintilimab combination therapy for the treatment of 48 patients with advanced malignant tumors.

Authors:  Nana Huang; Chenchen Zhao; Xueyang Hu; Congjun Zhang; Fuxing Xiong; Wei Huang; Liangshan Da; Yuanyuan Shen; Hongyang Wu
Journal:  Transl Cancer Res       Date:  2022-01       Impact factor: 1.241

Review 3.  Sintilimab for the treatment of non-small cell lung cancer.

Authors:  Lin Zhang; Weihao Lin; Fengwei Tan; Ning Li; Qi Xue; Shugeng Gao; Yibo Gao; Jie He
Journal:  Biomark Res       Date:  2022-04-18

4.  Rapid subcutaneous progression after immunotherapy in pretreated patients with metastatic carcinoma: two case reports.

Authors:  Yong Da; Ge Shen; Ming Zhou; Tao Wang; Dapeng Dong; Lina Bu; Yun Shao; Qiyun Sun; Ruoying Yu
Journal:  J Int Med Res       Date:  2022-04       Impact factor: 1.573

5.  Durable Response to Immunotherapy With Antiangiogenic Drug in Large-Cell Lung Carcinoma With Multiple Fulminant Postoperative Metastases: A Case Report.

Authors:  Zhilin Luo; Hong Zhang; Yajie Xiao; Rui Wang; Liping Zhang; Chenglu Huang; Yu Cao; Chao Sun; Yongtian Zhao; Hanqing Lin; Dongfang Wu; Tianhu Wang
Journal:  Front Oncol       Date:  2021-05-20       Impact factor: 6.244
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.